Chiesi and Gossamer collaborate to develop drug to treat respiratory diseases Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications
ALTURiX acquires exclusive UK rights to three new products The new products are in the areas of gastrointestinal and respiratory medicines